Crohn's disease and hyperbaric oxygen therapy.
OBJECTIVE
Evaluate the application of Hyperbaric Oxygen Therapy (HBO) in patients with Crohn's disease (CD) refractory to pharmacologic therapy, who developed abdominal, anorectal or skin complications.


METHODS
Fourteen selected patients with refractory CD and treated at the School of Medicine of Ribeirao Preto, University of Sao Paulo (FMRP-USP) and at the Center of Hyperbaric Medicine, São Paulo Hospital (CEMEHI) were submitted to HBO.


RESULTS
Of the 14 patients evaluated, 11 had a satisfactory response.


CONCLUSIONS
HBO has shown benefits in patients with CD refractory to pharmacologic therapy.
Department of Surgery and Anatomy, FMRP, USP, Ribeirao Preto, SP, Brazil.
Leonardo Estenio
LE
Iezzi
Marley Ribeiro
MR
Feitosa
Bruno Amaral
BA
Medeiros
Jussara C
JC
Aquino
Ana Luiza Normanha Ribeiro de
AL
Almeida
Rogerio Serafim
RS
Parra
José Joaquim Ribeiro da
JJ
Rocha
Omar
O
Féres
D000328:Adult; D003131:Combined Modality Therapy; D003424:Crohn Disease / Q000628:therapy*; D006801:Humans; D006931:Hyperbaric Oxygenation / Q000379:methods*; D008875:Middle Aged; D011446:Prospective Studies; D013997:Time Factors; D016896:Treatment Outcome; D055815:Young Adult